CBCatriona Jane Bhagra

Catriona Jane Bhagra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Catriona Jane Bhagra has a total of 142 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The impact of maternal postpartum body mass index on cardiovascular health at 1 year following pregnancy in Uganda

    by Tabitha Wishlade, Emmy Okello, Annette Kesiiga, Moses Adroma, Jackline Akello, Sheila Nabweyambo, Musa Sekikubo, Imelda Namagembe, Robert Kayesubula, Ronald Galiwango, et al.

  • Complete heart block in pregnancy: Review of current literature and case report

    by Magdalena Szybka, Brittany Jasper, Catriona Bhagra, Catherine E Aiken

    Complete heart block (CHB) in pregnancy is a rare condition, with acquired cases being particularly unusual. The management of CHB is guided by the underlying aetiology, symptoms, and associated risk factors, requiring careful consideration of both maternal and fetal well-being. This review examines the causes and pathophysiological mechanisms of CHB and discusses the pregnancy-related haemodynamic and hormonal changes that may exacerbate cardiac conduction abnormalities. We present the case of a 25-year-old woman diagnosed with acquired CHB at 18 weeks and 6 days of gestation, who underwent successful dual-chamber pacemaker implantation. This case illustrates the key aspects of managing CHB in pregnancy, including comprehensive diagnostic evaluation and careful delivery planning. Given the complexity of this clinical scenario, a multidisciplinary approach, including cardiologists, obstetricians and anaesthetists, is essential for optimising maternal and fetal outcomes. Further research is required to refine clinical guidelines and develop recommendations regarding long-term patient care and the management of subsequent pregnancies.

  • Pregnancy and breastfeeding in the mother with cardiomyopathy

    by Bianca Maria Coldea, Lucille Middleton, Catherine Aiken, Catriona J. Bhagra

    Cardiomyopathies are diseases of the heart muscle, characterised by structural and functional abnormalities of the myocardium that are not caused by ischemia, valvular problems or congenital heart disease. They are responsible for one-third of pregnancy-related cardiovascular deaths. A woman may enter pregnancy with a pre-existing diagnosis, or the cardiomyopathy may emerge or develop de novo during pregnancy. The most common cardiomyopathies encountered in pregnancy are dilated cardiomyopathy, hypertrophic cardiomyopathy and peripartum cardiomyopathy. All cardiomyopathies can be complicated by clinical heart failure, arrhythmia and thromboembolic events. Pregnancy may be poorly tolerated in women with dilated cardiomyopathy. New York Heart Association Class (NYHA) III/IV symptoms, and severe left ventricular dysfunction are the main determinants of adverse maternal outcomes. Peripartum cardiomyopathy is a diagnosis of exclusion with symptom onset towards the end of pregnancy, or within a few months following delivery. The management of heart failure and arrhythmias is based upon established guidelines, tailored for the unique considerations of pregnancy. Contemporary data suggests that recovery in cardiac function by 12 months is approximately 60–70% for the peripartum group. Maternal cardiovascular risk can be determined using specific risk-predictive scores. All patients with cardiomyopathy who wish to consider pregnancy should be offered individualized pre-conception and contraceptive counselling by a multidisciplinary team. This article reviews the management of women with cardiomyopathy during pregnancy and breastfeeding, focusing on the essential role of the multidisciplinary team at every stage of pregnancy and postpartum period to improve the maternal, fetal, and neonatal outcomes.

  • Reproductive health after thoracic transplantation: An ISHLT expert consensus statement

    by Michelle M. Kittleson, Ersilia M. DeFilippis, Catriona J. Bhagra, Jillian P. Casale, Matthew Cauldwell, Lisa A. Coscia, Rohan D'SOuza, Nicole Gaffney, Vicky Gerovasili, Patricia Ging, et al.


  • Cardiovascular and abdominal flow alterations in adults with morphologic evidence of liver disease post Fontan palliation

    by Elyar Abbasi Bavil, Hyun Kyung Yang, Matthew G. Doyle, Tae Kyoung Kim, Gauri Karur, Catriona Bhagra, Sai Bhagra, Erwin N. Oechslin, Heather Ross, S. Lucy Roche, et al.


  • Open Access

    A review of the management of patients with advanced heart failure in the intensive care unit

    by Caitlin Cheshire, Catriona Jane Bhagra, Sai Kiran Bhagra

    Despite progress in the medical and device therapy for heart failure (HF), the prognosis for those with advanced HF remains poor. Acute heart failure (AcHF) is the rapid development of, or worsening of symptoms and signs of HF typically leading to hospitalization. Whilst many HF decompensations are managed at a ward-based level, a proportion of patients require higher acuity care in the intensive care unit (ICU). Admission to ICU is associated with a higher risk of in-hospital mortality, and in those who fail to respond to standard supportive and medical therapy, a proportion maybe suitable for mechanical circulatory support (MCS). The optimal pre-operative management of advanced HF patients awaiting durable MCS or cardiac transplantation (CTx) is vital in improving both short and longer-term outcomes. This review will summarize the clinical assessment, hemodynamic profiling and management of the patient with AcHF in the ICU. The general principles of pre-surgical optimization encompassing individual systems (the kidneys, the liver, blood and glycemic control) will be discussed. Other factors impacting upon post-operative outcomes including nutrition and sarcopenia and pre-surgical skin decolonization have been included. Issues specific to durable MCS including the assessment of the right ventricle and strategies for optimization will also be discussed.


  • Pregnancy in a woman with a chronic descending thoracic aortic dissection

    by Govind Krishna Kumar Nair, Catriona Bhagra, Mathew Sermer, Candice K Silversides, Birgit Pfaller

    Pregnancy increases aortic wall stress and, for a woman with a chronic dissection, this can lead to extension of the dissection, aortic rupture, and death. We report a pregnancy in a woman with a history of a chronic type B aortic dissection. As a child, she had repeat balloon dilation of aortic coarctation, and one of the procedures was complicated by an iatrogenic dissection at the dilation site. At the age of 27 years, she had a planned pregnancy.


  • P6312Pregnancy outcomes in women with cardiothoracic transplants: a systematic review and meta-analysis

    by S Dong, R D'SOuza, S Acuna, N Zaffar, C Bhagra, C Silversides, H Ross

    Background: Increasing numbers of women with heart-lung transplants (HLT) are now planning and continuing with pregnancies. The risks of pregnancies in these women have not been systematically assessed. Methods: A search strategy was designed for MEDLINE, EMBASE, and Cochrane Central from inception to January 2018 to identify studies reporting outcomes in three or more pregnancies following HLT. Pooled incidence of maternal outcomes and fetal and neonatal outcomes were calculated using random-effects meta-analysis and reported per 100 pregnancies with 95% confidence intervals (CI). Risk-of-bias was determined using the Joanna Briggs Checklist for Case Series. Subgroup analysis was conducted based on transplanted organ. Results: A total of 3658 records were identified, 172 full texts reviewed, and 12 studies included. The included studies reported on 385 pregnancies in 272 transplant recipients. Maternal complications included mortality during pregnancy [0.5% (0, 1.1%)], mortality during the specified follow-up period [15.4% (10,4, 20.3%)], graft rejection during pregnancy [7.4% (4.2, 10.5%)], preeclampsia [12.3% (7.2%, 17.5%)], gestational diabetes [6.4% (2.6, 10.1%)], and caesarean deliveries [41.4% (33.4, 48.7%)]. As many as 78.4% (69.8, 86.9%) pregnancies resulted in live births. Of the remainder, 13.6% (6.3, 20.9%) resulted in miscarriages (fetal loss under 20 weeks of gestation), 2% (0.3, 3.7%) resulted in stillbirths (fetal loss after 20 weeks of gestation), and 6.8% (4.3, 9.3%) in pregnancy terminations for various reasons. Of those born live, 3.4% (1.3, 5.6%) succumbed in the neonatal period. Over half the pregnancies [51.2% (31, 71.3%)] resulted in preterm deliveries (<37 weeks of gestation). There were subgroup-specific variations in the prevalence of complications. For example, lung transplant recipients were less likely than heart transplant recipients to have pregnancies complicated by preeclampsia [8.3% (3.0, 13.6%) vs. 17.8% (10.8, 24.8%)] suffer maternal mortality during the follow up period [41.4% (23.4, 59.3%) vs. 10.8% (5.9, 15.8%)]. Studies had a moderate risk-of-bias. Conclusions: Although large proportions of pregnancies in women with HLT result in live births and few maternal deaths occur during pregnancy, these women are at increased risk for preeclampsia, preterm birth, perinatal mortality and maternal mortality following childbirth. Subgroup-specific variations should be taken into account while counselling HLT recipients contemplating pregnancies. Acknowledgement/Funding: None

  • Open Access

    Pregnancy in heart transplant recipients – current perspectives

    by William D Watson, Sai K. Bhagra, Catriona J. Bhagra

    Successful pregnancy with a live birth and preserved graft function is possible in women following cardiac transplantation but requires careful assessment and planning in conjunction with the co-ordinated care of a specialist multidisciplinary team. Pregnancy poses significant risks to the mother, graft and foetus; these include the challenges of managing immunosuppression to avoid rejection whilst balancing the risks to the foetus from potentially teratogenic medication. This article aims to provide a contemporary perspective on the issues pertaining to pregnancy in heart transplant recipients; describing the pre-conception, pre-partum, intrapartum and postpartum management in this unique group of women.